# Treatment of Elevated Blood Pressures in Early Pregnancy

> **NCT05955040** · PHASE2 · TERMINATED · sponsor: **Marshall University** · enrollment: 2 (actual)

## Conditions studied

- Elevated Blood Pressure
- Pregnancy Induced Hypertension

## Interventions

- **DRUG:** Nifedipine
- **DRUG:** Labetalol

## Key facts

- **NCT ID:** NCT05955040
- **Lead sponsor:** Marshall University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-11
- **Primary completion:** 2024-05-06
- **Final completion:** 2024-05-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study has closed due to difficulty in enrollment.
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05955040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05955040, "Treatment of Elevated Blood Pressures in Early Pregnancy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05955040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*